SCHEMBL28858691

SCHEMBL28858691

CC(=NSC(C)(C)C)c1ccc(-c2ccsc2)c([N+](=O)[O-])c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ EIF4E P06730 1/20 0.34
▸ MAPT P10636 6/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GAA P10253 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ PDE7A Q13946 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HCAR3 P49019 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18458701 0.82 ERN1 (0.37) ERN1ALDH1A1SMN1; SMN2EIF4EMAPT
SCHEMBL20210828 0.82 ERN1 (0.37) ERN1ALDH1A1SMN1; SMN2EIF4EMAPT
SCHEMBL18458311 0.80 MAPT (0.48) ERN1ALDH1A1SMN1; SMN2EIF4EMAPT
SCHEMBL18458067 0.76 CASP6 (0.55) ERN1EIF4EHCAR3TSHR
SCHEMBL28211106 0.75 ERN1 (0.41) ERN1ALDH1A1SMN1; SMN2EIF4EMAPT
SCHEMBL13011479 0.75 VCAM1 (0.52) ERN1ALDH1A1MAPTMEN1KMT2A
SCHEMBL28211113 0.70 HTT (0.54) ERN1ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL15741263 0.69 S100A4 (0.47) ERN1ALDH1A1EIF4EMAPTMAOB
SCHEMBL18458068 0.69 POLB (0.56) ALDH1A1SMN1; SMN2MAPTMEN1NPC1
SCHEMBL28211107 0.68 ERN1 (0.36) ERN1ALDH1A1EIF4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922375-A Target the antitumoral compounds and its application method of IDH2 mutation 正大天晴药业集团股份有限公司 2018-04-17 — — CN disclosed
Send feedback